关注
Jose A. Santiago
Jose A. Santiago
NeuroHub Analytics
在 neurohubanalytics.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Shared dysregulated pathways lead to Parkinson's disease and diabetes
JA Santiago, JA Potashkin
Trends in molecular medicine 19 (3), 176-186, 2013
2552013
The emerging role of nutrition in Parkinson's disease
SE Seidl, JA Santiago, H Bilyk, JA Potashkin
Frontiers in aging neuroscience 6, 74578, 2014
2472014
The impact of disease comorbidities in Alzheimer's disease
JA Santiago, JA Potashkin
Frontiers in aging neuroscience 13, 631770, 2021
1572021
System-based approaches to decode the molecular links in Parkinson's disease and diabetes
JA Santiago, JA Potashkin
Neurobiology of disease 72, 84-91, 2014
1072014
Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease
JA Santiago, JA Potashkin
Proceedings of the National Academy of Sciences 112 (7), 2257-2262, 2015
1052015
Biological and clinical implications of comorbidities in Parkinson’s disease
JA Santiago, V Bottero, JA Potashkin
Frontiers in aging neuroscience 9, 394, 2017
922017
Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes
JA Santiago, JA Potashkin
PloS one 8 (12), e83940, 2013
882013
Heterogeneous differentiation of human mesenchymal stem cells in response to extended culture in extracellular matrices
JA Santiago, R Pogemiller, BM Ogle
Tissue Engineering Part A 15 (12), 3911-3922, 2009
872009
Biosignatures for Parkinson’s disease and atypical parkinsonian disorders patients
JA Potashkin, JA Santiago, BM Ravina, A Watts, AA Leontovich
Public Library of Science 7 (8), e43595, 2012
752012
Dissecting the molecular mechanisms of neurodegenerative diseases through network biology
JA Santiago, V Bottero, JA Potashkin
Frontiers in aging neuroscience 9, 166, 2017
742017
A network approach to clinical intervention in neurodegenerative diseases
JA Santiago, JA Potashkin
Trends in molecular medicine 20 (12), 694-703, 2014
692014
Blood biomarkers associated with cognitive decline in early stage and drug-naive Parkinson’s disease patients
JA Santiago, JA Potashkin
PLoS One 10 (11), e0142582, 2015
412015
Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease
JA Santiago, CR Scherzer, JA Potashkin
PLoS One 9 (10), e109042, 2014
412014
Blood transcriptomic meta-analysis identifies dysregulation of hemoglobin and iron metabolism in Parkinson’disease
JA Santiago, JA Potashkin
Frontiers in Aging Neuroscience 9, 73, 2017
392017
Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease
JA Santiago, AM Littlefield, JA Potashkin
Scientific Reports 6 (1), 34579, 2016
382016
Transcriptomic and network analysis highlight the association of diabetes at different stages of Alzheimer’s disease
JA Santiago, V Bottero, JA Potashkin
Frontiers in Neuroscience 13, 498466, 2019
352019
Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer’s patients
JA Potashkin, V Bottero, JA Santiago, JP Quinn
PLoS One 14 (9), e0222921, 2019
262019
Evaluation of RNA blood biomarkers in the Parkinson’s disease biomarkers program
JA Santiago, V Bottero, JA Potashkin
Frontiers in aging neuroscience 10, 157, 2018
252018
Specific splice variants are associated with Parkinson's disease
JA Santiago, CR Scherzer, Harvard Biomarker Study, JA Potashkin
Movement disorders 28 (12), 1724-1727, 2013
252013
A network approach to diagnostic biomarkers in progressive supranuclear palsy
JA Santiago, JA Potashkin
Movement Disorders 29 (4), 550-555, 2014
232014
系统目前无法执行此操作,请稍后再试。
文章 1–20